Piramal Pharma Solutions says it has completed more than 200 customer audits across its global network over the past year, reporting strong overall outcomes. The company also states it received more than 70 approvals from regulatory agencies during the same period. The outlets describe the results as part of the firm’s longer-term quality strategy aimed at sustaining performance across its operations. While the news items highlight the scale of audit activity and the number of regulatory approvals, they do not provide additional details such as specific regulators, the locations covered, or audit and approval categories. The reporting presents the figures as a milestone reflecting quality and compliance efforts, but it does not include further metrics or context about prior-year performance. Overall, the coverage focuses on the company’s audit completion count, the regulatory approval tally, and the stated alignment with its quality-management approach.